Cargando…
Quantitative analysis questions the role of MeCP2 as a global regulator of alternative splicing
MeCP2 is an abundant protein in mature nerve cells, where it binds to DNA sequences containing methylated cytosine. Mutations in the MECP2 gene cause the severe neurological disorder Rett syndrome (RTT), provoking intensive study of the underlying molecular mechanisms. Multiple functions have been p...
Autores principales: | Chhatbar, Kashyap, Cholewa-Waclaw, Justyna, Shah, Ruth, Bird, Adrian, Sanguinetti, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584252/ https://www.ncbi.nlm.nih.gov/pubmed/33048927 http://dx.doi.org/10.1371/journal.pgen.1009087 |
Ejemplares similares
-
Absence of MeCP2 binding to non-methylated GT-rich sequences in vivo
por: Connelly, John C, et al.
Publicado: (2020) -
Neuronal non-CG methylation is an essential target for MeCP2 function
por: Tillotson, Rebekah, et al.
Publicado: (2021) -
A critique of the hypothesis that CA repeats are primary targets of neuronal MeCP2
por: Chhatbar, Kashyap, et al.
Publicado: (2022) -
MeCP2 mutations: progress towards understanding and treating Rett syndrome
por: Shah, Ruth R., et al.
Publicado: (2017) -
Quantitative modelling predicts the impact of DNA methylation on RNA polymerase II traffic
por: Cholewa-Waclaw, Justyna, et al.
Publicado: (2019)